Bulletin
Investor Alert

New York Markets Open in:

Syros Pharmaceuticals Inc.

NAS: SYRS

GO
/marketstate/country/us

Before the Bell

 --Quotes are delayed by 20 min

Aug 15, 2022, 4:25 a.m.

/zigman2/quotes/201168308/composite

$

0.96

Change

0.00 0.00%

Volume

Volume 100

Quotes are delayed by 20 min

/zigman2/quotes/201168308/composite

Previous close

$ 0.96

$ 0.96

Change

+0.03 +2.70%

Day low

Day high

$0.90

$0.98

Open

52 week low

52 week high

$0.65

$5.64

Open

Insider Actions for Syros Pharmaceuticals Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/01/2022 Nancy A. Simonian
President & CEO; Director
58,883   Derivative/Non-derivative trans. at $1.12 per share. 65,948
04/01/2022 Kristin Stephens
Chief Development Officer
14,115   Derivative/Non-derivative trans. at $1.12 per share. 15,808
04/01/2022 Eric R. Olson
Chief Scientific Officer
27,266   Derivative/Non-derivative trans. at $1.12 per share. 30,537
04/01/2022 David A. Roth
Chief Medical Officer
27,281   Derivative/Non-derivative trans. at $1.12 per share. 30,554
01/05/2022 Eric R. Olson
Chief Scientific Officer
2,208   Disposition at $3.47 per share. 7,661
07/01/2021 Eric R. Olson
Chief Scientific Officer
1,164   Disposition at $5.55 per share. 6,460
03/15/2021 Eric R. Olson
Chief Scientific Officer
3,628   Disposition at $9.47 per share. 34,357
03/15/2021 Eric R. Olson
Chief Scientific Officer
3,628   Derivative/Non-derivative trans. at $1.01 per share. 3,664
02/16/2021 Richard A. Young
Director
3,750   Disposition at $12.05 per share. 45,187
02/08/2021 Richard A. Young
Director
3,750   Disposition at $13.04 per share. 48,900
12/18/2020 Nancy A. Simonian
President & CEO; Director
4,988   Derivative/Non-derivative trans. at $10.09 per share. 50,328
12/18/2020 Nancy A. Simonian
President & CEO; Director
14,168   Derivative/Non-derivative trans. at $8.51 per share. 120,569
12/18/2020 Nancy A. Simonian
President & CEO; Director
10,761   Derivative/Non-derivative trans. at $3.04 per share. 32,713
12/08/2020 Samsara Biocapital LLC
Director
625,000   Award at $0 per share. 0
11/17/2020 Richard A. Young
Director
5,357   Disposition at $8.75 per share. 46,873
11/17/2020 Richard A. Young
Director
5,357   Disposition at $8.75 per share. 46,873
11/16/2020 Richard A. Young
Director
633   Disposition at $8.98 per share. 5,684
11/16/2020 Richard A. Young
Director
633   Disposition at $8.98 per share. 5,684

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
0 Sales
0
0
Last 6 months
0 Purchases
4 Sales
0
127,545
Last 12 months
0 Purchases
5 Sales
0
129,753

Officers and Executives

Dr. Nancy A. Simonian
President, Chief Executive Officer & Director
Mr. Jason Haas
Chief Financial Officer
Dr. Eric R. Olson
Chief Scientific Officer
Dr. David A. Roth
Chief Medical Officer
Ms. Kristin Stephen
Chief Development Officer
Mr. Conley Chee
Chief Commercial Officer
Dr. Richard A. Young
Director
Mr. Peter Wirth
Chairman
Mr. Mark J. Alles
Independent Director
Dr. S. Gail Eckhardt
Independent Director
Dr. Deborah L. Dunsire
Independent Director
Dr. Phillip A. Sharp
Independent Director
Ms. Marsha H. Fanucci
Independent Director
Dr. Amir H. Nashat
Independent Director
Dr. Srinivas Akkaraju
Independent Director
Link to MarketWatch's Slice.